dAVP [2746]



dAVP


SMILES NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CCSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O
InChIKey NFLWUMRGJYTJIN-UHFFFAOYSA-N
Sequence XYFQNCPRG
HELM PEPTIDE1{[*C(=O)CCS* |$_R2;;;;;;_R3$|].(Y,[dY]).(F,[dF]).(Q,[dQ]).(N,[dN]).(C,[dC]).(P,[dP]).(R,[dR]).G.[am]}$PEPTIDE1,PEPTIDE1,1:R3-6:R3$$$V2.0

Chemical Properties

Hydrogen bond acceptors 15
Hydrogen bond donors 13
Rotatable bonds 19
Log P -4.342
Molecular weight (Da) 1068.4
Stereochemistry info unspecified


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

dAVP


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.